- Chair of 'Ukraine 3000 International Charitable Foundation' honored for
her work to improve healthcare for Ukrainian children, women -
WASHINGTON, June 24 /PRNewswire/ -- Ukraine's "First Lady," American-born Kateryna Yushchenko has been awarded the first-ever MaxWell International Public Health Award for 2008.
The award is presented by MaxWell Biocorporation to an international public figure or organization that has made outstanding contributions to improving the health of under-served populations and demonstrated decisive leadership on public health issues.
Mrs. Yushchenko was chosen as the first recipient of the award in recognition of her service as Chair of the Ukraine 3000 International Charitable Foundation, her efforts on behalf of Ukraine's children, and her leadership in promoting early detection and treatment of breast cancer among Ukrainian women.
"Improved medical care in Ukraine is a priority for my husband, President Victor Yushchenko, and for my Foundation 'Ukraine 3000.' The health care sector in Ukraine is undergoing major change and improvement, but still needs much reform, investment, and training to bring it up to European standards," Mrs. Yushchenko wrote in a May 18 letter to Dr. Alibek.
"We appreciate MaxWell Biocorporation's investments into the Ukrainian health care sector and its efforts to provide Ukrainians with affordable, high quality pharmaceutical products and medical services," she added.
Dr. Ken Alibek, founder, President and CEO of MaxWell Biocorporation, presented the award to Mrs. Yushchenko during the opening of the MaxWell USA symposium "21st Century Pharmaceutical Production and Health Care Research & Delivery in the CIS." The symposium was held at the Ritz-Carlton in Washington, D.C. on May 28 (http://www.max-well.com/eng/press_whale.php).
Ukrainian Ambassador to the United States Oleh Shamshur received the award on behalf of Mrs. Yushchenko (http://www.max-well.com/img/photogallery/picture032_1.jpg).
MaxWell Biocorporation is a U.S.-based, privately-held international
medical and pharmaceutical company with wholly owned subsidiaries and
affiliates in the United States and Ukraine dedicated to increasing life
expectancy and improving the quality of life of people in Ukraine and other
underserved emerging healthcare markets in the former Soviet Union. MaxWell
targets oncological, cardiological, chronic infectious and autoimmune
disorders and diseases through the development, production, and
introduction into clinical practice of sophisticated, high quality, and
affordable off-patent generic biopharmaceutical and chemopharmaceutical
medicines and the latest diagnostic and therapeutic methods. MaxWell =
"We Help You Live Longer"
|SOURCE MaxWell Biocorporation|
Copyright©2008 PR Newswire.
All rights reserved